Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

68.31
+0.40000.59%
Post-market: 70.141.83+2.68%18:11 EST
Volume:2.51M
Turnover:171.06M
Market Cap:13.16B
PE:-16.33
High:68.97
Open:67.91
Low:67.11
Close:67.91
52wk High:84.94
52wk Low:28.33
Shares:192.71M
Float Shares:151.20M
Volume Ratio:0.70
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1844
EPS(LYR):-2.8793
ROE:-1789.67%
ROA:-43.47%
PB:-6.81
PE(LYR):-23.72

Loading ...

BridgeBio Pharma Q4 EPS $(1.00) Misses $(0.66) Estimate, Sales $154.178M Beat $146.844M Estimate

Benzinga
·
2 hours ago

BridgeBio Pharma Publishes Corporate Presentation on Rare Genetic Disease Drug Pipeline and Attruby Commercial Momentum

Reuters
·
2 hours ago

Earnings Flash (BBIO) BridgeBio Pharma Posts Q4 Loss $1, vs. FactSet Est of $0.71 Loss

MT Newswires Live
·
2 hours ago

BridgeBio reports Q4 EPS ($1.00), consensus (67c)

TIPRANKS
·
2 hours ago

BridgeBio Q4 revenue jumps on Attruby sales

Reuters
·
2 hours ago

BridgeBio posts USD 154.2 million Q4 total revenues, net on 35% QoQ net product revenue growth

Reuters
·
2 hours ago

BRIEF-BridgeBio Pharma Q4 Net Income USD -194.635 Million

Reuters
·
2 hours ago

BridgeBio Pharma: on Track for 1H 2026 Nda Submission Post Positive Phase 3 Calibrate Results for Encaleret in Adh1

THOMSON REUTERS
·
2 hours ago

BridgeBio Pharma Inc - Reports $154.2 Mln Q4 Revenues

THOMSON REUTERS
·
2 hours ago

BridgeBio Pharma Q4 EPS USD -1

THOMSON REUTERS
·
2 hours ago

U.S. Earnings Preview: After Market Close Feb. 24

Dow Jones
·
2 hours ago

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

BridgeBio Pharma CEO Neil Kumar Disposes of Common Shares

Reuters
·
Yesterday

Blue Owl, Genuine Parts, And Okta Are Among Top 10 Large Cap Losers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio?

Benzinga
·
Feb 22

BridgeBio Pharma Inc expected to post a loss of 74 cents a share - Earnings Preview

Reuters
·
Feb 21

BridgeBio off lows as traders discuss conference appearance

TIPRANKS
·
Feb 21

BridgeBio Pharma Director Scott Randal W. Reports Common Share Disposal

Reuters
·
Feb 19

Bank of America Securities Sticks to Its Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
Feb 18

BridgeBio Pharma Grants Equity Awards to 34 New Employees

Reuters
·
Feb 18

BridgeBio Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Feb 18